StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research note issued to investors on Saturday morning. The brokerage issued a sell rating on the stock.
Ampio Pharmaceuticals Price Performance
AMPE opened at $0.00 on Friday. Ampio Pharmaceuticals has a 52 week low of $0.00 and a 52 week high of $7.47. The company has a market cap of $2,497.00, a price-to-earnings ratio of 0.00 and a beta of 3.49.
Ampio Pharmaceuticals Company Profile
See Also
- Five stocks we like better than Ampio Pharmaceuticals
- What Are Dividend Achievers? An Introduction
- TJX Stock: A Buying Opportunity Before the Holiday Rush
- What Are Dividend Contenders? Investing in Dividend Contenders
- Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge
- What is a Bond Market Holiday? How to Invest and Trade
- Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
